|
|
|
Insider
Information: |
Schuler Jack W |
Relationship: |
|
City: |
Lake Forest |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
27,956,178 |
|
Indirect Shares
|
61,134,751 |
|
|
Direct
Value |
$202,708,978 |
|
|
Indirect Value
|
$172,941,055 |
|
|
Total
Shares |
89,090,929 |
|
|
Total
Value |
$375,650,033 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
54
|
96
|
Stock
price went up :
|
14
|
2
|
Stock
price went down : |
40
|
94
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-25.7%
|
-5,816.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VMSI |
Ventana Medical Systems I... |
Director |
|
2008-02-08 |
4 |
D |
$89.50 |
$251,028,347 |
D/D |
(2,804,786) |
0 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2015-12-15 |
4 |
B |
$17.00 |
$39,999,997 |
I/I |
2,352,941 |
11,238,178 |
2.25 |
- |
|
VMSI |
Ventana Medical Systems I... |
Director |
|
2008-02-08 |
4 |
D |
$89.50 |
$39,476,123 |
I/I |
(441,074) |
0 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2013-03-06 |
4 |
OE |
$1.03 |
$20,067,680 |
I/I |
13,428,840 |
27,428,840 |
0 |
- |
|
BDSX |
Biodesix Inc |
|
|
2023-08-03 |
4 |
A |
$1.62 |
$16,183,000 |
I/I |
9,989,506 |
30,579,359 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2014-05-19 |
4 |
A |
$16.80 |
$14,499,610 |
I/I |
863,072 |
10,639,992 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2012-06-26 |
4 |
B |
$1.03 |
$14,420,000 |
I/I |
14,000,000 |
14,000,000 |
2.25 |
- |
|
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2020-06-26 |
4 |
B |
$1.65 |
$12,500,002 |
I/I |
7,575,759 |
4,157,042 |
1.5 |
% |
|
BDSX |
Biodesix Inc |
Director |
|
2020-10-30 |
4 |
A |
$0.00 |
$10,853,784 |
I/I |
5,666,822 |
5,666,822 |
0 |
- |
|
BDSX |
Biodesix Inc |
|
|
2022-11-21 |
4 |
B |
$1.15 |
$10,000,000 |
I/I |
8,695,652 |
19,952,112 |
0.01 |
- |
|
BDSX |
Biodesix Inc |
Director |
|
2021-12-30 |
4 |
B |
$4.35 |
$9,999,998 |
I/I |
2,298,850 |
8,463,164 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2014-05-02 |
4 |
OE |
$16.80 |
$9,868,337 |
I/I |
587,401 |
9,776,920 |
0 |
- |
|
SRCL |
Stericycle Inc |
Director |
|
2010-06-02 |
4 |
S |
$59.08 |
$9,453,424 |
D/D |
(160,000) |
2,215,618 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-06-05 |
4 |
B |
$8.58 |
$9,438,000 |
I/I |
1,100,000 |
15,963,997 |
2.25 |
% |
|
SRCL |
Stericycle Inc |
Director |
|
2010-06-01 |
4 |
S |
$58.95 |
$9,431,584 |
D/D |
(160,000) |
2,375,618 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-11-01 |
4 |
B |
$2.80 |
$9,010,000 |
D/D |
3,217,857 |
7,780,721 |
2.45 |
- |
|
SRCL |
Stericycle Inc |
Director |
|
2012-12-13 |
4 |
S |
$93.38 |
$8,016,953 |
D/D |
(85,853) |
1,321,889 |
0 |
- |
|
AWH |
Aspira Womens Health Inc |
|
|
2020-07-01 |
4 |
B |
$3.50 |
$8,000,003 |
I/I |
2,285,715 |
25,394,517 |
0.01 |
- |
|
SRCL |
Stericycle Inc |
Director |
|
2009-03-13 |
4 |
S |
$48.56 |
$7,818,337 |
D/D |
(161,000) |
2,689,589 |
0 |
- |
|
SRCL |
Stericycle Inc |
Director |
|
2012-12-12 |
4 |
S |
$94.26 |
$7,787,384 |
D/D |
(82,616) |
1,407,742 |
0 |
- |
|
VMSI |
Ventana Medical Systems I... |
Director |
|
2008-01-23 |
4 |
OE |
$8.94 |
$7,286,144 |
D/D |
562,666 |
2,806,765 |
0 |
- |
|
VMSI |
Ventana Medical Systems I... |
Director |
|
2008-01-23 |
4 |
D |
$88.97 |
$7,285,575 |
D/D |
(81,888) |
2,804,786 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2016-02-09 |
4 |
B |
$11.86 |
$7,116,000 |
I/I |
600,000 |
11,955,586 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-01-09 |
4 |
B |
$19.00 |
$6,447,992 |
I/I |
339,368 |
952,678 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-11-06 |
4 |
B |
$18.51 |
$6,311,293 |
I/I |
340,964 |
1,293,642 |
2.25 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|